“COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER”. Genetics and Molecular Research (March 20, 2026). Accessed May 8, 2026. https://geneticsmr.com/index.php/gmr/article/view/598.